Deal Details

Regenity Receives Strategic Investment from Cinven

---

Summary

About

Regenity Biosciences is a leading global developer and manufacturer of bioresorbable technologies used to repair and regenerate natural tissue and bone for a variety of markets including dental, spine, orthopedic, sports medicine, advanced wound, neurosurgery, ENT and nerve repair. Regenity’s product portfolio includes a variety of collagen-based and synthetic polymer solutions that support the company’s platform for tissue and bone regeneration. Regenity develops proprietary products that are sold to OEM customers on either a contract or private label basis and offers partnership opportunities including contract product development and manufacturing services. Founded in 1997, Regenity (formerly Collagen Matrix, Inc.) has manufacturing locations in Oakland and Allendale, New Jersey and Groningen, the Netherlands and is headquartered in Paramus, New Jersey.

Linden Capital Partners is a private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is the largest dedicated healthcare private equity firm. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise and (iii) its differentiated human capital program. Since its founding, Linden has invested in over 50 healthcare companies encompassing over 400+ total transactions across its strategies. The firm currently manages ~$14 billion of regulatory assets under management. Linden is headquartered in Chicago, Illinois.

Cinven is a leading international private equity firm focused on building world-class global and European companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and Technology, Media and Telecommunications (TMT). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid and Luxembourg. Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society. Cinven Limited is authorized and regulated by the Financial Conduct Authority. Cinven Fund Management S.à r.l. is authorized and regulated by the Commission de Surveillance du Secteur Financier. ‘Cinven’ means, depending on the context, any of or collectively, Cinven Holdings Guernsey Limited, Cinven Partnership LLP and their respective Associates (as defined in the Companies Act 2006) and/or funds managed or advised by any of the foregoing. Cinven is headquartered in London, United Kingdom.

---

CONTACT US TO LEARN MORE